The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Mixed 20-peptide cancer vaccine in combination with docetaxel and dexamethasone for castration-resistant prostate cancer: A randomized, double-blind, placebo-controlled, phase 2 trial.
 
Masanori Noguchi
Consulting or Advisory Role - BrightPath Biotheraputics
 
Gaku Arai
No Relationships to Disclose
 
Shin Egawa
No Relationships to Disclose
 
Chikara Ohyama
No Relationships to Disclose
 
Seiji Naito
Consulting or Advisory Role - BrightPath Biotheraputics
 
Kazumasa Matsumoto
No Relationships to Disclose
 
Hirotsugu Uemura
No Relationships to Disclose
 
Masayuki Nakagawa
No Relationships to Disclose
 
Yasutomo Nasu
No Relationships to Disclose
 
Masatoshi Eto
No Relationships to Disclose
 
Shigetaka Suekane
No Relationships to Disclose
 
Tetsuro Sasada
No Relationships to Disclose
 
Shigeki Shichijo
No Relationships to Disclose
 
Akira Yamada
Employment - BrightPath Biotheraputics
Stock and Other Ownership Interests - BrightPath Biotheraputics
 
Tatsuyuki Kakuma
No Relationships to Disclose
 
Kyogo Itoh
Research Funding - Taiho Pharmaceutical (Inst)